Olumese 1999.
Methods | Trial design: open label RCT Trial dates: not stated |
|
Participants | Number of participants: 103 children aged 11 months to 5 years enrolled Inclusion criteria: Children aged 6 months to 5 years satisfying the WHO criteria for cerebral malaria, viz. unrousable coma lasting more than 30 minutes (with or without convulsions) with the presence of peripheral P falciparum parasitaemia were included in the trial. Exclusion criteria: none stated |
|
Interventions |
Loading dose quinine was omitted in patients with a positive history of quinine or mefloquine ingestion in the preceding 24 hours before hospital presentation. |
|
Outcomes | Outcomes included in the review:
Outcomes not included in the review:
|
|
Notes | Location: Emergency Paediatric ward, University College Hospital, Ibadan, Nigeria Transmission: unknown Funding: World Bank/UNDP/WHO special fund for Research and Training in Tropical Diseases (TDR) |
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | Computer‐generated allocation. |
Allocation concealment (selection bias) | Unclear risk | Methods not described by trial authors. |
Blinding (performance bias and detection bias) Objective outcome: Death | Low risk | Unlikely to be biased whether blinding was done or not. |
Blinding (performance bias and detection bias) Subjective outcomes: Others | High risk | No information of blinding reported by authors. Blinding unlikely as artemether and quinine were given by 2 different routes. |
Incomplete outcome data (attrition bias) All outcomes | Low risk | No losses to follow‐up recorded. |
Selective reporting (reporting bias) | Low risk | No evidence of selective reporting. |
Other bias | Low risk | No other bias identified. |